4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-23-004039
CEO and President sold 12,286 shares at $1.81 ($22,238)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahadevia Ankit CEO and President | 2023-02-03 | Sale | −12,286 | $1.81 | $22,238 | 797,832 | D |
| Open-market sales · 12,286 sh · avg $1.81 · $22,238 | |||||||
Loading xslF345X03/doc4.xml…